In this podcast, expert clinicians will discuss practices, procedures, and treatments that can improve the detection and treatment of ocular surface and dry eye disease.

https://healio.com/cme/mededtalks/ophthalmology/20241211/1-ocular-surface-and-lid-health-collaborative-care-a-focus-on-dry-eye-disease

In this podcast, expert clinicians will discuss practices, procedures, and treatments that can improve the detection and treatment of ocular surface disease and Demodex blepharitis.

https://healio.com/cme/mededtalks/ophthalmology/20241211/2-ocular-surface-and-lid-health-collaborative-care-a-focus-on-lid-health

In this podcast, expert clinicians will discuss interprofessional approaches that can increase efficiency and improve ocular surface and lid health in patients.

https://healio.com/cme/mededtalks/ophthalmology/20241211/3-ocular-surface-and-lid-health-collaborative-care-a-focus-on-collaborative-practice

Geographic atrophy (GA) is a progressive, degenerative disease whose development is associated with modifiable and nonmodifiable risk factors, including mutations in specific genes involved in the regulation of the complement system. Multimodal imaging is crucial for the early diagnosis and determination of GA progression, with current recommendations highlighting optical coherence tomography as the primary imaging modality for detecting biomarkers associated with progression. Two novel therapies that target components of the complement system were approved by the FDA in 2023 allowing for personalized, long-term management of GA. In this CE activity, experts in the field review the latest imaging tools for the early diagnosis and monitoring of disease progression; evaluate clinical and imaging characteristics associated with disease progression in different phenotypes; and assess individualized treatment selection for patients with GA secondary to age-related macular degeneration (AMD). Rapid-Fire Roundtable discussion will further examine practical methods and procedures that can facilitate the optimal implementation of imaging modalities and therapies into the management of patient with GA secondary to AMD.

https://healio.com/cme/mededtalks/ophthalmology/20241202/ga-secondary-to-amd-optimizing-long-term-outcomes-through-refined-treatment-selection

Geographic atrophy (GA) is a progressive, degenerative disease whose development is associated with modifiable and nonmodifiable risk factors, including mutations in specific genes involved in the regulation of the complement system. Multimodal imaging is crucial for the early diagnosis and determination of GA progression, with current recommendations highlighting optical coherence tomography as the primary imaging modality for detecting biomarkers associated with progression. Two novel therapies that target components of the complement system were approved by the FDA in 2023 allowing for personalized, long-term management of GA. In this CE activity, experts in the field review the latest imaging tools for the early diagnosis and monitoring of disease progression; evaluate clinical and imaging characteristics associated with disease progression in different phenotypes; and assess individualized treatment selection for patients with GA secondary to age-related macular degeneration (AMD). Rapid-Fire Roundtable discussion will further examine practical methods and procedures that can facilitate the optimal implementation of imaging modalities and therapies into the management of patient with GA secondary to AMD.

https://healio.com/cme/mededtalks/ophthalmology/20241202/ga-secondary-to-amd-optimizing-long-term-outcomes-through-refined-treatment-selection

In this podcast, Drs. Lisa Nijm and Barry Lee discuss recent advances in therapy for lid margin conditions such as meibomian gland dysfunction and Demodex blepharitis. Faculty review management strategies supported by the latest clinical evidence, highlighting new and emerging treatment options to improve ocular health. https://healio.com/cme/mededtalks/ophthalmology/20241126/2-meibomian-gland-dysfunction-and-lid-margin-disease-imperfect-together

In this podcast, Drs. Lisa Nijm and Francis Mah discuss recent advances for optimizing the ocular surface, including evidence-based approaches for treating dry eye disease. This educational podcast focuses on enhanced formulations for treating DED, as well as emerging agents targeting novel mechanisms of action. https://healio.com/cme/mededtalks/ophthalmology/20241126/1-enhancing-the-ocular-surface-new-formulations-and-novel-mechanisms-of-action

In this podcast, expert clinicians will discuss the latest data from gene therapy trials and review the efficacy and safety of various delivery approaches. 

https://healio.com/cme/mededtalks/ophthalmology/20241114/9-the-retina-radar-with-dr-arshad-khanani-gene-therapy-in-2024

In this podcast, expert clinicians will discuss the mechanism of action of tyrosine kinase inhibitors and the latest clinical data on their use in the treatment of retinal diseases. 

https://healio.com/cme/mededtalks/ophthalmology/20241114/10-the-retina-radar-with-dr-arshad-khanani-tyrosine-kinase-inhibitors

In this podcast, expert clinicians will discuss the latest information and emerging clinical trial data regarding the management of DR and DME.

https://healio.com/cme/mededtalks/ophthalmology/20241022/8-the-retina-radar-with-dr-arshad-khanani-noninvasive-treatments-for-dr-and-dme